300 related articles for article (PubMed ID: 16013906)
1. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs.
Lamberti JS; Crilly JF; Maharaj K; Olson D; Wiener K; Dvorin S; Costea GO; Bushey MP; Dietz MB
J Clin Psychiatry; 2004 May; 65(5):702-6. PubMed ID: 15163259
[TBL] [Abstract][Full Text] [Related]
4. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
[TBL] [Abstract][Full Text] [Related]
5. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.
Henderson DC; Nguyen DD; Copeland PM; Hayden DL; Borba CP; Louie PM; Freudenreich O; Evins AE; Cather C; Goff DC
J Clin Psychiatry; 2005 Sep; 66(9):1116-21. PubMed ID: 16187768
[TBL] [Abstract][Full Text] [Related]
6. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of the metabolic syndrome among patients receiving clozapine.
Lamberti JS; Olson D; Crilly JF; Olivares T; Williams GC; Tu X; Tang W; Wiener K; Dvorin S; Dietz MB
Am J Psychiatry; 2006 Jul; 163(7):1273-6. PubMed ID: 16816234
[TBL] [Abstract][Full Text] [Related]
8. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
9. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
[TBL] [Abstract][Full Text] [Related]
11. Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.
Nihalani ND; Tu X; Lamberti JS; Olson D; Olivares T; Costea GO; Tang W
Ann Clin Psychiatry; 2007; 19(2):105-12. PubMed ID: 17612850
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
[TBL] [Abstract][Full Text] [Related]
13. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
[TBL] [Abstract][Full Text] [Related]
14. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
[TBL] [Abstract][Full Text] [Related]
15. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
[TBL] [Abstract][Full Text] [Related]
16. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
17. Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.
Sernyak MJ; Gulanski B; Rosenheck R
J Clin Psychiatry; 2005 Nov; 66(11):1463-7. PubMed ID: 16420085
[TBL] [Abstract][Full Text] [Related]
18. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
Melkersson KI; Hulting AL; Brismar KE
J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
[TBL] [Abstract][Full Text] [Related]
19. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients.
Lappin JM; Wijaya M; Watkins A; Morell R; Teasdale S; Lederman O; Rosenbaum S; Dick S; Ward P; Curtis J
Schizophr Res; 2018 Sep; 199():367-373. PubMed ID: 29486959
[TBL] [Abstract][Full Text] [Related]
20. Switching clozapine responders to olanzapine.
Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
